Skip to content

Uterine Artery Doppler and 11-14 / 20-22 Weeks of Gestation Pregnancy

Comparison of Uterine Artery Doppler Measurements Performed at 11-14 and 20-22 Weeks of Gestation During Pregnancy According to Delivery Type and Number of Births and Investigation of the Effects on Obstetric Outcomes (Maternal, Fetal, Neonatal Results)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04248660
Enrollment
750
Registered
2020-01-30
Start date
2016-01-01
Completion date
2020-01-01
Last updated
2020-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy Related

Keywords

Uterine artery doppler, type of delivery, obstetric outcomes

Brief summary

Uterine artery doppler measurements will be made at 11-14 weeks and 20-22 weeks of gestation, and the classification of these measurements according to type of delivery; and to investigate the change in the effect of delivery type on uterine artery flows on obstetric outcomes (maternal, fetal, neonatal outcomes).

Detailed description

The first and second trimester perinatal examination results performed by the same operator from pregnant women who have applied to the clinic since the first trimester are removed from the ViewPoint 6.0 server and database and their uterine artery doppler values (uterine artery PI and RI values, presence of uterine artery notch), placental location, gestational week of measurement, blood pressures, PAPP-A and hCG MoM values, obstetric results (type of birth, week, weight, ante-postpartum complications), data to be generated from other hospital records will be saved to the base

Interventions

OTHERuterine artery doppler measurement

The effect of delivery type on changes in uterine blood flow will be investigated. Doppler results groups will be defined according to the effect of deviations in uterine blood flow on neonatal and perinatal results.

Sponsors

Kanuni Sultan Suleyman Training and Research Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Gestational age 11-14. applying to the outpatient clinic at week * Single spontaneous pregnancy * Having a first pregnancy (primigravid nullipar) or having given birth once (primipar) (first birth by vaginal route or cesarean) * Result of previous pregnancy with live birth (term delivery without obstetric complication) * No intrauterine growth restriction in the first pregnancy * Women who gave birth by cesarean section were not placed due to caesarean indication due to placental location-invasion anomaly, maternal chronic disease (hypertension, diabetes, coronary artery disease, etc.), placental detachment.

Exclusion criteria

* Multiple pregnancies * Pregnancies with assisted reproductive techniques * Placental anomaly in previous pregnancy * Maternal chronic hypertension, preeclampsia, history of diabetes * Pregnant women who smoke * The presence of fetal chromosomal or structural anomaly * two or more cesarean sections * Having undergone non-cesarean surgery (myomectomy, septum or polyp resection ... etc) * Presence of uterine structural anomaly

Design outcomes

Primary

MeasureTime frameDescription
Doppler results of 11-14 weeks of gestation in patients with previous cesarean section10 monthsuterine artery doppler values (uterine artery PI , presence of uterine artery notch)
Doppler results of 11-14 weeks of gestation in those who gave birth beforehand10 monthsuterine artery doppler values (uterine artery PI , presence of uterine artery notch)
Doppler results of 20-22 weeks of gestation in patients with previous cesarean section10 monthsuterine artery doppler values (uterine artery PI , presence of uterine artery notch)
Doppler results of 20-22 weeks of gestation in those who gave birth beforehand10 monthsuterine artery doppler values (uterine artery PI , presence of uterine artery notch)

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026